Quince Therapeutics vs Verdiva Bio

Quince Therapeutics vs Verdiva Bio, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Quince Therapeutics is on 37/100 and Verdiva Bio on 54/100.

Quince Therapeutics logo
Quince TherapeuticsA biopharmaceutical company focused on developing novel therapies.
Try Quince Therapeutics
Verdiva Bio logo
Verdiva BioClinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
Try Verdiva Bio

Where each one leads

Quince Therapeutics

  • agent readiness: 39/100 against 21/100
  • domain rating: 38/100 against 23/100

Verdiva Bio

  • our overall score: 54/100 against 37/100
  • funding raised: $170M against $63.0M

At a glance

MeasureQuince TherapeuticsVerdiva Bio
What it isA biopharmaceutical company focused on developing novel therapies.Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
CategoryBiotechnology, Pharmaceuticals, HealthcareBiotechnology, Pharmaceuticals, HealthTech, Medical Devices
Sells toBusiness modelB2BB2B
OfferingServicesServices
Founded20202021
HeadquartersSouth San Francisco, USASan Diego, United States
StatusActiveActive

Size, funding and growth

MeasureQuince TherapeuticsVerdiva Bio
EmployeesNot published74
Total funding$63.0M$170M
Latest roundSeries CSeries B
Valuation$1.1BNot published
LinkedIn followersNot published6,379

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureQuince TherapeuticsVerdiva Bio
StartupHub scoreOur 0-100 rating37/10054/100
Traction39/10059/100
CommunityNot published8/100
Search visibility13/10034/100
Quality45/10068/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)F (21/100)
Domain ratingLink authority, 0-10038/10023/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureQuince TherapeuticsVerdiva Bio
HostingAWSSelf Managed
CMSWordPressWordPress
FrameworksJqueryJquery
AnalyticsJetpack StatsGoogle Analytics 4

Quince Therapeutics vs Verdiva Bio: common questions

Which is better, Quince Therapeutics or Verdiva Bio?

On our 0-100 score Verdiva Bio rates higher (54/100 against 37/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.

How do Quince Therapeutics and Verdiva Bio compare on the numbers?

Quince Therapeutics leads on agent readiness (39/100 against 21/100), domain rating (38/100 against 23/100). Verdiva Bio leads on our overall score (54/100 against 37/100), funding raised ($170M against $63.0M).

Read the full Quince Therapeutics review and pricing or the Verdiva Bio review and pricing. You can also browse other Quince Therapeutics alternatives we track.